Your browser doesn't support javascript.
loading
Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts.
Crépin, Ronan; Gentien, David; Duché, Angeline; Rapinat, Audrey; Reyes, Cecile; Némati, Fariba; Massonnet, Gérald; Decaudin, Didier; Djender, Selma; Moutel, Sandrine; Desrumeaux, Klervi; Cassoux, Nathalie; Piperno-Neumann, Sophie; Amigorena, Sebastian; Perez, Franck; Roman-Roman, Sergio; de Marco, Ario.
Afiliação
  • Crépin R; Tumor Target and Therapeutic Antibody - Identification Platform (TAb-IP), Paris Cedex 05, France.
  • Gentien D; Translational Research Department, Institut Curie, PSL Research University, Paris, France.
  • Duché A; Translational Research Department, Institut Curie, PSL Research University, Paris, France.
  • Rapinat A; Translational Research Department, Institut Curie, PSL Research University, Paris, France.
  • Reyes C; Translational Research Department, Institut Curie, PSL Research University, Paris, France.
  • Némati F; Translational Research Department, Institut Curie, PSL Research University, Paris, France.
  • Massonnet G; Translational Research Department, Institut Curie, PSL Research University, Paris, France.
  • Decaudin D; Translational Research Department, Institut Curie, PSL Research University, Paris, France.
  • Djender S; Medical Oncology Department, Institut Curie, Paris Cedex 05, France.
  • Moutel S; Tumor Target and Therapeutic Antibody - Identification Platform (TAb-IP), Paris Cedex 05, France.
  • Desrumeaux K; Institut Curie, PSL Research University, Paris Cedex 05, France.
  • Cassoux N; Translational Research Department, Institut Curie, PSL Research University, Paris, France.
  • Piperno-Neumann S; Institut Curie, PSL Research University, Paris Cedex 05, France.
  • Amigorena S; UMR144, Institut Curie, Paris, France.
  • Perez F; Tumor Target and Therapeutic Antibody - Identification Platform (TAb-IP), Paris Cedex 05, France.
  • Roman-Roman S; Department of Surgical Oncology, Institut Curie, Paris, France.
  • de Marco A; Department of Medical Oncology, Institut Curie, Paris, France.
Pigment Cell Melanoma Res ; 30(3): 317-327, 2017 05.
Article em En | MEDLINE | ID: mdl-28140525
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Neoplasias Uveais / Biomarcadores Tumorais / Heterogeneidade Genética / Anticorpos de Domínio Único / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pigment Cell Melanoma Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Neoplasias Uveais / Biomarcadores Tumorais / Heterogeneidade Genética / Anticorpos de Domínio Único / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pigment Cell Melanoma Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França